Form 4: Fulgent Genetics Chief Scientific Officer Sells Shares to Cover Tax Obligations

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 497 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, sold 497 shares of common stock on November 25, 2024.
• The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 23, 2023.
• The shares were sold at a weighted-average price of $18.2593, with individual transaction prices ranging from $18.12 to $18.50.
• Following the transaction, Gao beneficially owns 920,842 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no significant positive or negative implications for the company's performance or outlook.

Industry Context

This is a routine transaction for company executives to manage their tax obligations related to stock-based compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The sale of 497 shares by the Chief Scientific Officer is a relatively small transaction compared to the total shares held and is not unusual.
• Similar transactions are regularly reported by executives at comparable companies in the biotechnology and healthcare sectors.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant given the small number of shares sold.

Key Dates

Keywords

Fulgent Genetics, Hanlin Gao, stock sale, insider trading, tax obligations, restricted stock units, FLGT